Coral Laboratories appoints cost auditor for FY27

1 min read     Updated on 30 May 2026, 10:55 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Coral Laboratories Limited has appointed M/s Aatish Dhattrak & Associates as its Cost Auditor for FY27, effective May 30, 2026. The Board approved the appointment following the Audit Committee's recommendation. The firm is unrelated to the company's directors.

powered bylight_fuzz_icon
41707488

*this image is generated using AI for illustrative purposes only.

Coral Laboratories Limited has appointed M/s Aatish Dhattrak & Associates as its Cost Auditor for the financial year 2026-2027. The appointment, effective from May 30, 2026, was approved by the Board of Directors based on the recommendation of the Audit Committee. This move ensures compliance with regulatory requirements governing cost audits for the upcoming fiscal year.

The decision was formalized during the Board meeting held on May 30, 2026. M/s Aatish Dhattrak & Associates, a partnership firm of Cost Accountants, brings extensive expertise in cost audit, accounts, audit, risk management, and project management. The firm holds a Firm Registration Number (FRN) of 101575.

Appointment Details

The company disclosed that there are no relationships between the newly appointed Cost Auditor and the directors of Coral Laboratories Limited. The appointment falls under the category of a new engagement rather than a change from a previous auditor.

Key Information

Detail Description
Name M/s Aatish Dhattrak & Associates (FRN: 101575)
Designation Cost Auditor
Reason for Change Appointment
Date of Appointment May 30, 2026
Tenure Financial Year 2026-2027
Relationship with Directors Not applicable

Historical Stock Returns for Coral Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+1.52%+4.29%+20.96%+5.38%-18.74%+7.23%

What specific cost control measures does Coral Laboratories plan to implement with the new auditor's expertise?

How will the appointment impact the company's operational efficiency and profit margins in FY 2026-2027?

Are there any upcoming regulatory changes that might influence the scope of cost audits for Coral Laboratories?

Coral Labs board to consider Q4FY26 results on May 30

0 min read     Updated on 20 May 2026, 02:40 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Coral Laboratories Limited has scheduled a board meeting for May 30, 2026, to consider the standalone audited financial results for the quarter and year ended March 31, 2026. The agenda includes the recommendation of a final dividend, if any, and the appointment of internal and cost auditors for FY27. The trading window is closed from April 1, 2026, until 48 hours after the results declaration.

powered bylight_fuzz_icon
40813692

*this image is generated using AI for illustrative purposes only.

Coral Laboratories Limited has scheduled a meeting of its Board of Directors for Saturday, May 30, 2026. The meeting will be held to consider and approve the standalone audited financial results for the quarter and financial year ended March 31, 2026. The board will also evaluate the recommendation of a final dividend on equity shares for the year ended March 31, 2026, if any.

Agenda for the Meeting

The board's agenda includes several key administrative and financial approvals. Alongside the financial results, the directors will consider the appointment of an Internal Auditor and a Cost Auditor for the upcoming financial year 2026-27. The meeting will also cover any other business with the permission of the chairman.

Trading Window Closure

In accordance with the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the equity shares of the company has been closed. This restriction commenced on Wednesday, April 1, 2026, and will remain closed until 48 hours after the declaration of the financial results.

The intimation was signed by Sushma Kadkade, Director & CFO, on May 20, 2026, in Mumbai.

Historical Stock Returns for Coral Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+1.52%+4.29%+20.96%+5.38%-18.74%+7.23%

How does Coral Laboratories' expected dividend payout for FY2026 compare to its historical dividend track record, and what does it signal about the company's financial health?

What impact could the audited financial results for FY2026 have on Coral Laboratories' stock price movement once the trading window reopens?

How might the appointment of new Internal and Cost Auditors for FY2026-27 influence Coral Laboratories' operational efficiency and cost management strategies going forward?

More News on Coral Laboratories

1 Year Returns:-18.74%